On December 20, 2022, the Federal Trade Commission (“FTC”) announced its issuance of Health Products Compliance Guidance, which updates and replaces its previous 1998 guidance, Dietary Supplements: An Advertising Guide for Industry. While the FTC notes that the basic content of the guide is largely left unchanged, this guidance expands the scope of the previous guidance beyond dietary supplements to broadly include claims made about all health-related products, such as foods, over-the-counter drugs, devices, health apps, and diagnostic tests. This updated guidance emphasizes “key compliance points” drawn from the numerous enforcement actions brought by the FTC since 1998, and discusses associated examples related to topics such as claim interpretation, substantiation, and other advertising issues.
Identifying Claims and Interpreting Advertisement Meaning
The updated guidance first discusses how claims are identified and interpreted, including the difference between express and implied claims. The updated guidance emphasizes that the phrasing and context of an advertisement may imply that the product is beneficial to the treatment of a disease, which in turn would require that the advertiser be able to substantiate the implied claim with competent and reliable scientific evidence, even if the advertisement contains no express reference to the disease.
In addition, the updated guidance provides examples of when advertisers are expected to disclose qualifying information, such as when a product is targeted to a small percentage of the population or contains potentially serious risks. When the qualifying information is necessary to avoid deception, the updated guidance contains a discussion of what constitutes a clear and conspicuous disclosure of that qualifying information. Specifically, the guidance states that a disclosure is required to be provided in the same manner as the claim (i.e., if the claim is made visually, the disclosure is required to be made visually). A visual claim should stand out, and based on its size, contract, location, and length of time is appears, must be easily noticed, read, and understood. An audible disclosure should be at a volume, speed, and cadence so as to be easily heard and understood. On social media, the guidance states a disclosure should be “unavoidable,” which the FTC clarifies does not include hyperlinks. The qualifying information should not include vague qualifying terms, such as that a product “may” have benefits or “helps” achieve a benefit.
Continue Reading FTC Issues New Guidance Regarding Health Products